Pharmagreen Biotech Inc. (PHBI)
- Previous Close
0.0007 - Open
0.0008 - Bid --
- Ask --
- Day's Range
0.0007 - 0.0008 - 52 Week Range
0.0003 - 0.0059 - Volume
803,578 - Avg. Volume
1,504,028 - Market Cap (intraday)
464,552 - Beta (5Y Monthly) 1.55
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Pharmagreen Biotech Inc. operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. Its primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. The company also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for cultivation and live storage of any plant species services. It sells its products through online stores, such as Amazon and Shopify. Pharmagreen Biotech Inc. is headquartered in Coquitlam, Canada.
www.pharmagreen.ca--
Full Time Employees
September 30
Fiscal Year Ends
Sector
Recent News: PHBI
Performance Overview: PHBI
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PHBI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PHBI
Valuation Measures
Market Cap
464.55k
Enterprise Value
858.72k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
208.19
Price/Book (mrq)
--
Enterprise Value/Revenue
550.46
Enterprise Value/EBITDA
-2.12
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-140.89%
Return on Equity (ttm)
--
Revenue (ttm)
4.23k
Net Income Avi to Common (ttm)
-674.25k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
743
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
369.48k
Company Insights: PHBI
PHBI does not have Company Insights